The next chapter for group B meningococcal vaccines

The next chapter for group B meningococcal vaccines

The majority of invasive meningococcal disease (IMD) in the developed world is caused by capsular group B Neisseria meningitidis, however success with vaccination against organisms bearing this capsule has previously been restricted to control of geographically limited clonal outbreaks. As we enter...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Wang, N, Pollard, A
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Taylor and Francis 2017

Gelijkaardige items

Group B meningococcal vaccine science and policy
door: Drysdale, SB, et al.
Gepubliceerd in: (2015)

Group B meningococcal vaccine: Recommendations for UK use
door: Pollard, A, et al.
Gepubliceerd in: (2014)

Group B meningococcal vaccine: recommendations for UK use.
door: Pollard, A, et al.
Gepubliceerd in: (2014)

Four component meningococcal capsular Group B vaccine in preterm infants.
door: Sadarangani, M, et al.
Gepubliceerd in: (2017)

Meningococcal vaccines.
door: Rüggeberg, J, et al.
Gepubliceerd in: (2004)

Meningococcal vaccines.
door: Collins, C, et al.
Gepubliceerd in: (2002)

Meningococcal vaccines.
door: Bethell, D, et al.
Gepubliceerd in: (2002)

Serogroup B meningococcal vaccines-an unfinished story.
door: Sadarangani, M, et al.
Gepubliceerd in: (2010)

The capsular group B meningococcal vaccine, 4CMenB : clinical experience and potential efficacy.
door: Rollier, C, et al.
Gepubliceerd in: (2014)

Quadrivalent meningococcal conjugate vaccines
door: Pace, D, et al.
Gepubliceerd in: (2009)

Quadrivalent meningococcal conjugate vaccines.
door: Pace, D, et al.
Gepubliceerd in: (2009)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
door: Rivero-Calle I, et al.
Gepubliceerd in: (2019-10-01)

Vaccines for prevention of meningococcal disease.
door: Pollard, A, et al.
Gepubliceerd in: (2000)

An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease
door: Dold, C, et al.
Gepubliceerd in: (2023)

Challenges and progress in the development of a serogroup B meningococcal vaccine.
door: Lewis, S, et al.
Gepubliceerd in: (2009)

Gonococcal Vaccine Development: Lessons from Group B Meningococcal Vaccines
Gepubliceerd in: (2017-08-01)

Meningococcal meningitis presenting postinfant group B meningococcal immunisation
door: So, N, et al.
Gepubliceerd in: (2018)

Safety of meningococcal group B vaccination in hospitalised premature infants
door: Kent, A, et al.
Gepubliceerd in: (2018)

The epidemiology of meningococcal disease and the impact of vaccines.
door: Khatami, A, et al.
Gepubliceerd in: (2010)

Meningococcal disease and vaccination in North America.
door: Pollard, A, et al.
Gepubliceerd in: (2001)

Reconsideration of the use of meningococcal polysaccharide vaccine.
door: Granoff, D, et al.
Gepubliceerd in: (2007)

Meningococcal polysaccharide-protein conjugate vaccines.
door: Snape, MD, et al.
Gepubliceerd in: (2005)

Impact of meningococcal group B OMV vaccines, beyond their brief
door: Helen Petousis-Harris
Gepubliceerd in: (2018-05-01)

Development of group B meningococcal vaccine: a progress review
door: Wei ZHAO, et al.
Gepubliceerd in: (2022-08-01)

Global epidemiology of meningococcal disease and vaccine efficacy
door: Pollard, A
Gepubliceerd in: (2004)

Global epidemiology of meningococcal disease and vaccine efficacy.
door: Pollard, A
Gepubliceerd in: (2004)

Emerging clinical experience with vaccines against group B meningococcal disease
door: Wilkins, A, et al.
Gepubliceerd in: (2017)

Vaccine prevention of meningococcal disease, coming soon?
door: Morley, S, et al.
Gepubliceerd in: (2001)

Vaccine prevention of meningococcal disease, coming soon?
door: Morley, S, et al.
Gepubliceerd in: (2001)

Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules
door: Sadarangani, M, et al.
Gepubliceerd in: (2017)

Enter B and W: two new meningococcal vaccine programmes launched.
door: Ladhani, S, et al.
Gepubliceerd in: (2016)

Enter B and W: two new meningococcal vaccine programmes launched
door: Ladhani, S, et al.
Gepubliceerd in: (2015)

Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activity.
door: James B Wing, et al.
Gepubliceerd in: (2012-01-01)

Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine
door: Weissmueller, N, et al.
Gepubliceerd in: (2017)

Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps
door: F. Marc LaForce, et al.
Gepubliceerd in: (2018-05-01)

Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine
door: O'Connor, D, et al.
Gepubliceerd in: (2020)

Meningococcal disease
door: Pollard, A
Gepubliceerd in: (2018)

Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine
door: Daniel O’Connor, et al.
Gepubliceerd in: (2020-11-01)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.
door: Read, R, et al.
Gepubliceerd in: (2014)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: An observer-blind, phase 3 randomised clinical trial
door: Read, R, et al.
Gepubliceerd in: (2014)